Chronic myeloid leukaemia trials in Portugal

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Lisbon, Porto

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00